Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-26 | New | $4,250,000 | $4,250,000 | Equity Only | 06b | SEC link |
| 2024-10-25 | New | $790,000 | $790,000 | Other | 06b | SEC link |
| 2023-01-20 | New | $4,000,000 | $4,000,000 | Other | 06b | SEC link |
| 2022-08-15 | New | $125,000 | $125,000 | Debt Only | 06b | SEC link |
| 2022-02-22 | New | $365,000 | $365,000 | Debt Only | 06b | SEC link |
| 2022-01-04 | New | $500,000 | $500,000 | Debt Only | 06b | SEC link |
| 2019-01-31 | New | $912,500 | $912,500 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| William Adkins | Director |
| Milton Brown | Director |
| Christopher Cooper | Executive |
| Peter Dritschillo | Executive |
| Peter Dritschilo | Executive |
| Anatoly Dritschilo | Director, Executive |
| Amir Heshmatpour | Director |
| Bette Jacobs | Director |
| Mira Jung | Executive |
| Timothy Lorber | Executive |
| Oleh Nabyt | Director |
| Tyvin Rich | Executive |
| Steven Richards | Director |
| Josh Schafer | Director |
| Joshua Schafer | Director |
| George Scorcis | Director |
| Chris Senanayake | Director |
| Joseph Tung | Director |
| Michael Vander Hoek | Executive |